
[ 2025-2026 ]
ElfieResearch
A patient-centric B2B clinical-research platform
[ target ]
Design an end-to-end trial platform across 6 distinct personas, reframing electronic consent from a legal formality into an interactive learning experience.
[ Constraints ]
Audit trail was a design constraint from day one.
[ reframe from insights ]
While most platforms optimize for sponsors, we realized that a great participant experience is what actually drives retention.
This reframed the entire brief.
Instead of starting with the admin console, we focused on where trials usually break down: onboarding. That made eConsent the natural starting point—not just as a legal signature to collect, but as an accessible first impression and a crucial comprehension test.
[ scope ]
[ Key Decisions ][ System ]
Draw the permission model before the screens
Mapping six roles against seven classes of data made the overlap visible: the roles differ in the depth of their access, not in the objects they touch. Per-role applications would duplicate one data model rather than specialise it.
[ Key Decisions ][ the builder ]
Design the builder, not the form
Protocol amendments force re-consent, and every version of every form has to stay retrievable for audit. So the deliverable was the tool that makes the form. One primitive carries four modules: participant identification, screening, eConsent and withdrawal.
[ Key Decisions ][ the builder at work • screening ]
Branch the screening, not the study
Eligibility is routed per answer, in sentences a coordinator can read: if greater than 18, go to Q2. Every unhandled case falls to a named ending screen, so no participant can leave the flow undecided.
[ Key Decisions ][ econsent ]
Turn consent into comprehension
Consent was scoped as a legal formality. FDA guidance on decentralised trials treats the eConsent system as where understanding is established, not only recorded. We argued for building the participant surface before the console, starting with consent.


[ Key Decisions ][ Retention ]
Design for the participant who is alone
A decentralised participant has no waiting room and no nurse. Isolation drives dropout, and the control arm receives least by design. Reminders, visible progress and streak mechanics are configurable per arm; recruitment is drawn as four separately tracked sources.


[ Key Decisions ][ the states ]
Design the states nobody demos
A regulated product is judged on the paths a demo skips. Each of these exists as a designed screen in the file, not as a note for engineering.
[ outcome ]
Complete multi-platform flows (console, web, mobile) in just 1 month from the initial PRD publication.
eConsent (End-to-end flows for electronic consent); ePRO / eCOA (Electronic patient-reported outcomes) ; Patient Recruitment (Landing page + pre-screening / eligibility flow); Console (Role-based web console used by trial staff.)

[ reflection ]
Positioning eConsent as a critical retention lever did more than improve the user experience - It anchored our design strategy directly to business KPIs, ensuring design and product were finally speaking the same language.














